Hester Biosciences Limited has informed the Exchange about Copy of Newspaper Publication

Hester Biosciences has submitted copies of newspaper clippings containing its audited consolidated and standalone financial results for the quarter and year ended 31 March 2025, as required under SEBI Listing Regulations. The results were published on 10 May 2025 in the Ahmedabad editions of Financial Express (English and Gujarati). For the full year, standalone total income rose to Rs 3,057.48 million (from Rs 2,832.86 million in FY24) and standalone net profit after tax increased to Rs 288.85 million (from Rs 271.35 million). On a consolidated basis, total income grew to Rs 3,150.26 million (from Rs 2,894.17 million), while consolidated net profit after tax was nearly flat at Rs 314.79 million versus Rs 319.53 million. The Board has also recommended a dividend for shareholders, subject to approval at the upcoming Annual General Meeting.